Hemoperfusion with Seraph-100 in septic patients removes pathogens and improves clinical outcomes Antonio Lacquaniti, Antonella Smeriglio, Fabrizio Ceresa, Susanna Campo, Daniele Caruso, Giuseppe Falliti, Erminia La Camera, Francesco Patané, Domenico Trombetta, Paolo Monardo Scientific Reports, 2025 Hemoperfusion (HP) represents a treatment option for sepsis. This study evaluated Seraph-100 in septic patients admitted to the intensive care unit (ICU) after cardiac surgery due to infective endocarditis (IE). Thirteen septic patients were enrolled and treated by Seraph-100 hemoperfusion. Fiftenne patients, not treated by HP, represented a control group. Pathogens were assessed before (T0) and after 4 h of HP treatment (T4). The difference between the two- quantification cycle (Cq) values (T0 and T4), namely ∆Cq at the polymerase chain reaction, was a surrogate marker of pathogen removal. The bacterial load decreased after Seraph-100 HP, with a mean ∆Cq values of 4.6 ± 2.4, as corroborated by conventional haemoculture’s results. Field Emission Scanning Electron Microscopy analyses confirm the Seraph’ adsorptive properties. Procalcitonin, C reactive protein and lactates significantly decreased, with a reduced ICU stay in the Seraph group. After HP, only 15% of patients had AKI requiring renal replacement therapy (RRT), significantly lower than that found in the control group (40%). The Seraph-100 HP induces a decrease of vasopressor doses, a hemodynamic stability and a reduction of AKI and RRT, improving the clinical course, reflected as a reduced ICU stay.
Acute Kidney Injury, Renal Replacement Therapy, and Extracorporeal Membrane Oxygenation Treatment During the COVID-19 Pandemic: Single-Center Experience Fabrizio Ceresa, Paolo Monardo, Antonio Lacquaniti, Liborio Francesco Mammana, Aurora Leonardi, Francesco Patanè Medicina Lithuania, 2025 Background and Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) was described in December 2019 for the first time, and it was responsible for a global pandemic. An alarming number of patients with coronavirus disease 2019 (COVID-19) also developed acute kidney injury (AKI), especially those who required extracorporeal membrane oxygenation (ECMO) therapy for acute respiratory distress syndrome (ARDS). The aim of our retrospective observational study was to assess the prognostic significance of AKI in these patients. This study observed, in COVID-19 patients admitted to an intensive care unit (ICU), AKI stages and the need for renal replacement therapy (RRT), assessing the risk factors and outcomes. Moreover, we evaluated the mortality rate of patients treated by ECMO. Materials and Methods: Between November 2020 and December 2022, among 396 patients admitted to our intensive care unit (ICU) diagnosed with SARS-CoV-2 infection, we selected patients with severe ARDS requiring veno-venous (vv) ECMO support and AKI. Results: The 30-day mortality after ECMO positioning was 85.7%. A Cox regression revealed a significant advantage for RRT with a high cut-off (HCO) hemofilter both for ICU mortality (HR 0.17 [95% CI: 0.031–0.935], p = 0.035) and 15 day-mortality after the start of vv-ECMO (HR 0.13 [95%CI: 0.024–0.741], p= 0.021), whereas the early onset of vasoplegic shock after ECMO implantation indicated a higher risk of death (HR 11.55 [95% CI: 1.117–119.567], p = 0.04) during the ICU stay. Conclusions: COVID-19 induces a high risk of AKI and RRT. In our cohort, hypertension, pre-existing renal disease, and mechanical ventilation represented independent risk factors for AKI. Patients requiring ECMO support had a high mortality rate. The early implementation of RRT reduced the risk of death during the ICU stay.
A case of LIMA side branch coronary steal syndrome: a role for embolization Andrea Picci, Giuseppe Certo, Fabrizio Ceresa, Francesco Patanè Catheterization and Cardiovascular Interventions, 2024 Failure to close the side branches of the internal mammary artery can result in ischemia due to coronary steal through a patent mammary artery side branch after coronary artery bypass grafting. The authors present the case of a 56‐year‐old man with recurrent angina after 6 month surgical myocardial revascularization underwent coronary angiography that showed patent left branch of the internal mammary artery. After demonstration of inducible ischemia, effective percutaneous treatment was performed using coil embolization, improving blood flow and clinical symptoms.
Performance of the Mammoth Balloon Catheter in Patients with Severe Aortic Valve Stenosis Undergoing Percutaneous Treatment Silvia Moscardelli, Rodolfo Caminiti, Carolina Montonati, Fabrizio Ceresa, Giuseppe De Blasio, Giampiero Vizzari, Dario Pellegrini, Mariano Pellicano, Giulio Guagliumi, Francesco Patanè, Maurizio Tespili, Antonio Micari, Alfonso Ielasi Journal of Clinical Medicine, 2024 Background: Balloon aortic valvuloplasty (BAV) is currently used as pre-treatment for patients undergoing trans-catheter aortic valve replacement (TAVR) as well as a stand-alone option for subjects with significant contraindications to TAVR. Mammoth is a newly available non-compliant balloon catheter (BC) included in the balloon-expandable Myval THV system (Meril Life Sciences Pvt. Ltd., India). As limited data on the performance of this BC are available, we here report the results following its use for BAV as pre-dilatation during TAVR or as a stand-alone procedure. Methods: A retrospective, single-center cohort analysis was performed on patients with severe aortic valve stenosis (AS) treated with the Mammoth BC at IRCCS Ospedale Galeazzi Sant’Ambrogio, Milan, Italy. The primary endpoint was technical success defined as successful Mammoth BC advancement across the AS followed by its full and homogeneous inflation without major complications such as aortic root/left ventricular outflow tract injury and/or stroke. Results: A total of 121 patients were treated by BAV with Mammoth BC during the study period. Among these, 105 patients underwent BAV pre-dilatation before TAVR while 16 patients underwent a stand-alone BAV procedure. Mammoth BC was delivered and successfully inflated at the target site in all of the 121 cases without BC-related complications (100% technical success). However, in the BAV “stand-alone group”, three patients required two different balloon sizes while in nine patients multiple rounds (two to three) of balloon inflation were needed to significantly lower the transvalvular gradient. No cases of aortic root injury or massive aortic regurgitation due to Mammoth BC-related aortic leaflet injury were reported while one major stroke occurred late after TAVR. No intra-procedural deaths occurred nor bleeding (BARC 3-4) or major vascular complication. Conclusions: Mammoth BC use in patients with severe AS proved safe and effective, either before TAVR or as a stand-alone procedure, expanding the range of available tools for structural operators.
Veno-arterial extracorporeal membrane oxygenation supported transcatheter aortic valve implantation in a high-risk COVID-19 patient: A comprehensive case report Giampiero Vizzari, Tommaso De Ferrari, Francesco Costa, Nastasia Mancini, Marco Franzino, Fabrizio Ceresa, Francesco Patanè, Antonio Micari European Heart Journal Case Reports, 2024 Background The sudden onset of heart failure in high-risk transcatheter aortic valve implantation (TAVI) candidates poses significant challenges, necessitating meticulous planning and consideration of mechanical circulatory support options. Nevertheless, existing data on the efficacy and safety of mechanical circulatory support in this context are limited, along with criteria for patient selection. Case summary An 87-year-old patient, with severe low-flow low-gradient aortic stenosis, presented with acute heart failure and concurrent COVID-19 pneumonia. Despite initial conservative management, her clinical condition deteriorated, requiring inotropic support. The decision was made to perform a rescue TAVI procedure with veno-arterial extracorporeal membrane oxygenation (ECMO) support. The patient underwent successful TAVI while managing complications, including cardiac arrest, with haemodynamic support from veno-arterial ECMO. Post-procedure, the patient showed improved cardiac function and was discharged in stable condition. Discussion This case underscores the significance of strategic patient selection, proactive haemodynamic management, and the judicious use of veno-arterial ECMO in high-risk TAVI, particularly in complex scenarios involving acute heart failure and respiratory insufficiency, exacerbated by COVID-19. It highlights the challenges and critical decision points in TAVI planning, emphasizing the need for further research and standardized guidelines to refine indications for prophylactic mechanical circulatory support in TAVI procedures.
SURgical vs. PERcutaneous ACCESS in Transfemoral Transcatheter Aortic Valve Implantation (SU-PER-ACCESS Study) Antonio Giovanni Cammardella, Marco Russo, Michele Di Mauro, Claudia Romagnoni, Fabrizio Ceresa, Francesco Patanè, Guido Gelpi, Francesco Pollari, Fabio Barili, Alessandro Parolari, Federico Ranocchi Journal of Clinical Medicine, 2024 Background: The transfemoral (TF) approach is the most common route in TAVI, but it is still associated with a risk of bleeding and vascular complications. The aim of this study was to compare the clinical outcomes between surgical cut-down (SC) and percutaneous (PC) approach. (2) Methods: Between January 2018 and June 2022, 774 patients underwent a transfemoral TAVI procedure. After propensity matching, 323 patients underwent TAVI in each group. (3) Results: In the matched population, 15 patients (4.6%) in the SC group vs. 34 patients in the PC group (11%) experienced minor vascular complications (p = 0.02), while no difference for major vascular complication (1.5% vs. 1.9%) were reported. The rate of minor bleeding events was higher in the percutaneous group (11% vs. 3.1%, p <.001). The SC group experienced a higher rate of non-vascular-related access complications (minor 8% vs. 1.2%; major 2.2% vs. 1.2%; p < 0.001). (4) Conclusions: SC for TF-TAVI did not alter the mortality rate at 30 days and was associated with reduced minor vascular complication and bleeding. PC showed a lower rate of non-vascular-related access complications and a lower length of stay. The specific approach should be tailored to the patient’s clinical characteristics.
Percutaneous Coronary Intervention before or after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis Involving 1531 Patients Rodolfo Caminiti, Alfonso Ielasi, Giampaolo Vetta, Antonio Parlavecchio, Domenico Giovanni Della Rocca, Dario Pellegrini, Mariano Pellicano, Carolina Montonati, Nastasia Mancini, Gabriele Carciotto, Manuela Ajello, Giustina Iuvara, Francesco Costa, Giulia Laterra, Marco Barbanti, Fabrizio Ceresa, Francesco Patanè, Antonio Micari, Giampiero Vizzari Journal of Clinical Medicine, 2024 Background: The optimal timing to perform percutaneous coronary interventions (PCIs) in patients undergoing transcatheter aortic valve replacement (TAVR) is not well established. In this meta-analysis, we aimed to compare the outcomes of patients undergoing PCI before versus after TAVR. Methods: A comprehensive literature search was performed including Medline, Embase, and Cochrane electronic databases up to 5 April 2024 for studies that compared PCI before and after TAVR reporting at least one clinical outcome of interest (PROSPERO ID: CRD42023470417). The analyzed outcomes were mortality, stroke, and myocardial infarction (MI) at follow-up. Results: A total of 3 studies involving 1531 patients (pre-TAVR PCI n = 1240; post-TAVR PCI n = 291) were included in this meta-analysis following our inclusion criteria. Mortality was higher in the pre-TAVR PCI group (OR: 2.48; 95% CI: 1.19–5.20; p = 0.02). No differences were found between PCI before and after TAVR for the risk of stroke (OR: 3.58; 95% CI: 0.70–18.15; p = 0.12) and MI (OR: 0.66; 95% CI: 0.30–1.42; p = 0.29). Conclusions: This meta-analysis showed in patients with stable CAD undergoing TAVR that PCI after TAVR is associated with lower mortality compared with PCI before TAVR.
Surgical Aortic Valve Replacement and Renal Dysfunction: From Acute Kidney Injury to Chronic Disease Antonio Lacquaniti, Fabrizio Ceresa, Susanna Campo, Antonella Smeriglio, Domenico Trombetta, Francesco Patanè, Paolo Monardo Journal of Clinical Medicine, 2024 Background: Surgical aortic valve replacement (SAVR) is often complicated by acute kidney injury (AKI). Identifying patients at risk of AKI is important to start nephroprotective strategies or renal replacement therapy (RRT). This study investigated the incidence and risk factors of post-operative AKI in SAVR patients. Chronic kidney disease (CKD) developed in the post-cardiac-surgery follow-up period was also assessed. Methods: A total of 462 SAVR patients were retrospectively enrolled. The primary endpoint was the occurrence rate of AKI after surgery. Kidney recovery, during two planned outpatient clinic nephrological visits within 12 months after the surgery, was assessed. Results: A total of 76 patients experienced an AKI event. A Kaplan–Meier analysis revealed that subjects with CKD stage IV had a time to progression of 2.7 days, compared to patients with stages I–II, who were characterized by the slowest progression time, >11.2 days. A Cox regression indicated that CKD stages predicted a higher risk of AKI independently of other variables. During their ICU stay, 23 patients died, representing 5% of the population, most of them requiring RRT during their ICU stay. A severe CKD before the surgery was closely related to perioperative mortality. During the follow-up period, 21 patients with AKI worsened their CKD stage. Conclusions: AKI represents a common complication for SAVR patients in the early post-operative period, prolonging their ICU stay, with negative effects on survival, especially if RRT was required. Pre-operative CKD >3 stage is an independent risk factor for AKI in patients undergoing SAVR.
Left Ventricular Mass Index Predicts Renal Function Decline in Patients with Chronic Kidney Disease Antonio Lacquaniti, Fabrizio Ceresa, Susanna Campo, Francesco Patané, Paolo Monardo Medicina Lithuania, 2024 Background and Objectives: Several studies revealed a relation between abnormal cardiac remodeling and glomerular filtration rate (GFR) decline, but there are limited data regarding echocardiographic changes in chronic kidney disease (CKD). This study evaluated the abnormal cardiac structures characterizing patients with CKD, assessing the independent association between echocardiographic parameters and the risk of decline in renal function. Materials and Methods: In total, 160 patients with CKD were studied. All patients underwent an echocardiographic exam and 99mTc-DTPA renal scintigraphy to measure the GFR. After the baseline assessments, patients were followed prospectively for 12 months, or until the endpoint achievement, defined as a worsening in renal function (doubling of baseline serum creatinine, GFR decline ≥25%, the start of dialysis). Results: Patients with GFR values of 34.8 ± 15 mL/min, identifying stages III–IV of CKD, were associated with high levels of left ventricular mass index (LVMi) (101.9 ± 12.2 g/m2), which was related to proteinuria, systolic blood pressure, and pulmonary artery systolic pressure in a multiple regression model. During the observational period, 26% of patients reached the endpoint. Regression analysis revealed LVMi as a predictor of change in renal function after adjusting for kidney and cardiac risk factors. Multiple Cox regression indicated that an increase in LVMi was associated with a 12% increased risk of kidney disease progression (HR: 1.12; 95% CI: 1.04–1.16; p = 0.001). Conclusions: In patients with CKD, high LVMi represents an independent predictor of the progressive decline of the renal function, until the start of renal replacement therapy. Echocardiography can help identify patients at high risk for renal disease worsening in patients with CKD independently of clinical cardiac involvement.
Replacement of Ascending Aortic Aneurysm with Anomalous Origin of the Right Coronary Artery: Multidisciplinary Imaging for the Diagnosis Fabrizio Ceresa, Antonio Micari, Liborio Francesco Mammana, Umberto Maisano, Alessandro Di Carlo, Alfredo Luongo, Francesco Patanè Journal of Cardiovascular Echography, 2023 This case report presents a rare scenario involving a congenital anomaly of the right coronary artery’s (RCA) origin in association with an ascending aortic aneurysm. While both anomalies are individually recognized in the literature, their coexistence and potential interplay remain understudied. The aim of this report is to emphasize the challenges and implications associated with such a combination. A 78-year-old male patient with an enlarged ascending aortic aneurysm necessitating surgical intervention was found to have an anomalous origin of the RCA during preoperative coronary angiography, confirmed by computed tomography scan. Transesophageal echocardiography further elucidated the coronary abnormality. Intraoperatively, successful aortic replacement was performed, and careful repositioning of the anomalous right coronary ostium was achieved. This case raises important considerations regarding the potential complications arising from coronary anomalies and their impact on the surgical management of ascending aortic aneurysms. The rarity of this combination limits our understanding of their association, making a multidisciplinary approach crucial for optimal patient care. Further research and comprehensive evaluation of similar cases are necessary to better understand the relationship between coronary anomalies and ascending aortic aneurysms. Such investigations will help in improving treatment strategies and outcomes for patients with these complex conditions.
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease Alessandro Caracciolo, Renato Francesco Maria Scalise, Fabrizio Ceresa, Gianluca Bagnato, Antonio Giovanni Versace, Roberto Licordari, Silvia Perfetti, Francesca Lofrumento, Natasha Irrera, Domenico Santoro, Francesco Patanè, Gianluca Di Bella, Francesco Costa, Antonio Micari Journal of Clinical Medicine, 2022
Aortic Valve Surgery in Nonelderly Patients: Insights Gained From AVIATOR Emmanuel Lansac, Pouya Youssefi, Frederiek de Heer, Joseph Bavaria, Laurent De Kerchove, Ismail El-Hamamsy, Gebrine Elkhoury, Maurice Enriquez-Sarano, Laurent de Guillaume Jondeau, Jolanda Kluin, Philippe Pibarot, Hans-Joachim Schäfers, Jean-Louis Vanoverschelde, Johanna J.M. Takkenberg, Christian Dinges, Johannes Steindl, Rosina Ziller, Taoufik Benkacem, Corinne Coulon, Fadoua Kaddouri, Christophe de Meester, Agnès Pasquet, Jan Nijs, Veerle Van Mossevelde, Bart Loeys, Bart Meuris, Evi Schepmans, Klaartje Van den Bossche, Peter Verbrugghe, Wenke Goossens, Herbert Gutermann, Matteo Pettinari, Marien Lenoir, Pierre-Emmanuel Noly, Michael Tousch, Pallav Shah, Munir Boodhwani, Igor Rudez, Davor Baric, Daniel Unic, Josip Varvodic, Savica Gjorgijevska, Jan Vojacek, Pavel Zacek, Mikita Karalko, Jaroslav Hlubocky, Robert Novotny, Andrey Slautin, Said Soliman, Eric Arnaud-Crozat, Aude Boignard, Georges Fayad, Olivier Bouchot, Bernard Albat, Alain Leguerrier, Fabien Doguet, Jean-François Fuzellier, Yves Glock, Guy Fernandez, Didier Chatel, David Messika Zeitoun, Jérôme Jouan, Isabelle Di Centa, Jean-François Obadia, Pascal Leprince, Rémi Houel, Eric Bergoend, Stéphane Lopez, Alain Berrebi, Florence Tubach, Jean-Luc Monin, Sarah Pousset, Leila Mankoubi, Milean Noghin, Christelle Diakov, Daniel Czytrom, Michael Borger, Diana Aicher, Svenja Rauch, Frank Theisohn, Paolo Ferrero, Serban Stoica, Maciej Matuszewski, Patrick Yiu, Mohamad Bashir, Fabrizio Ceresa, Francesco Patane, Ruggero De Paulis, Ilaria Chirichilli, Mauro Masat, Carlo Antona, Monica Contino, Andrea Mangini, Claudia Romagnoni, Francesco Grigioni, Rubina Rosa, Yutaka Okita, Takeshi Miyairi, Takashi Kunihara, Dave Koolbergen, Jos Bekkers, Robert Klautz, Thomas Van Brakel, Bardia Arabkhani, Gianclaudio Mecozzi, Ryan Accord, Marek Jasinski, Vladislav Aminov, Mihail Svetkin, Adrian Kolesar, František Sabol, Tomas Toporcer, Ignacio Bibiloni, Gregorio Rábago, Virginia Alvarez-Asiain, Amaia Melero, Rafael Sadaba, José Aramendi, Alejandro Crespo, Carlos Porras, Arturo Evangelista Masip, Rita Milewski, Patrick Moeller, Isaac Wenger, Christine Leon, Jean Marc Marnette, Vincent Doisy, Fabrice Wautot, Thierry Bourguignon, Duke Cameron, Edward Chen Seminars in Thoracic and Cardiovascular Surgery, 2019
AVIATOR: An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm Frederiek de Heer, Jolanda Kluin, Gebrine Elkhoury, Guillaume Jondeau, Maurice Enriquez-Sarano, Hans-Joachim Schäfers, Johanna J.M. Takkenberg, Emmanuel Lansac, Christian Dinges, Johannes Steindl, Rosina Ziller, Laurent De Kerchove, Taoufik Benkacem, Corinne Coulon, Gebrine Elkhoury, Fadoua Kaddouri, Jean-Louis Vanoverschelde, Christophe de Meester, Agnès Pasquet, Jan Nijs, Veerle Van Mosselvelde, Bart Loeys, Bart Meuris, Evi Schepmans, Klaartje Van den Bossche, Peter Verbrugghe, Wenke Goossens, Herbert Gutermann, Matteo Pettinari, Ismail El-Hamamsy, Marien Lenoir, Pierre-Emmanuel Noly, Michael Tousch, Pallav Shah, Munir Boodhwani, Igor Rudez, Davor Baric, Daniel Unic, Josip Varvodic, Savica Gjorgijevska, Jan Vojacek, Pavel Zacek, Mikita Karalko, Jaroslav Hlubocky, Robert Novotny, Andrey Slautin, Said Soliman, Eric Arnaud-Crozat, Aude Boignard, Georges Fayad, Olivier Bouchot, Bernard Albat, Alain Leguerrier, Fabien Doguet, Jean-François Fuzellier, Yves Glock, Guillaume Jondeau, Guy Fernandez, Didier Chatel, David Messika Zeitoun, Jérôme Jouan, Isabelle Di Centa, Jean-François Obadia, Pascal Leprince, Rémi Houel, Eric Bergoend, Stéphane Lopez, Alain Berrebi, Florence Tubach, Emmanuel Lansac, Stéphanie Lejeune, Jean-Luc Monin, Sarah Pousset, Leila Mankoubi, Milean Noghin, Christelle Diakov, Daniel Czytrom, Hans-Joachim Schäfers, Michael Borger, Diana Aicher, Frank Theisohn, Paolo Ferrero, Serban Stoica, Maciej Matuszewski, Patrick Yiu, Mohamad Bashir, Fabrizio Ceresa, Francesco Patane, Ruggero De Paulis, Ilaria Chirichilli, Mauro Masat, Carlo Antona, Monica Contino, Andrea Mangini, Claudia Romagnoni, Francesco Grigioni, Rubina Rosa, Yutaka Okita, Takeshi Miyairi, Takashi Kunihara, Frederiek de Heer, Dave Koolbergen, Mandy Marsman, Arjen Gökalp, Jolanda Kluin, Jos Bekkers, Liesbeth Duininck, Johanna J.M. Takkenberg, Robert Klautz, Thomas Van Brakel, Bardia Arabkhani, Gianclaudio Mecozzi, Ryan Accord, Marek Jasinski, Vladislav Aminov, Mihail Svetkin, Adrian Kolesar, František Sabol, Tomas Toporcer, Ignacio Bibiloni, Gregorio Rábago, Virginia Alvarez-Asiain, Amaia Melero, Rafael Sadaba, José Aramendi, Alejandro Crespo, Carlos Porras, Arturo Evangelista Masip, Shelagh Kelley, Joseph Bavaria, Rita Milewski, Patrick Moeller, Isaac Wenger, Maurice Enriquez-Sarano, Stan Alger, Aurelie Alger, Katie Leavitt Journal of Thoracic and Cardiovascular Surgery, 2019
A prospective study of prevalence of 60-days postoperative wound infections after cardiac surgery. An updated risk factor analysis Journal of Cardiovascular Surgery, 2007
Reply Paolo Centofanti, Roberto Flocco, Fabrizio Ceresa, Matteo Attisani, Michele La Torre, Luca Weltert, Antonio M. Calafiore Annals of Thoracic Surgery, 2007
Reply Paolo Centofanti, Roberto Flocco, Fabrizio Ceresa, Matteo Attisani, Michele La Torre, Luca Weltert, Antonio M. Calafiore Annals of Thoracic Surgery, 2007
